{"entity":{"type":"insider","cik":"0001286541","url":"/insider/0001286541","json_url":"/insider/0001286541.json","name":"OBP MANAGEMENT IV LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":9,"first":"2004-06-04","last":"2006-10-20","span_basis":"filed_date"},"name_variants":[{"name":"OBP MANAGEMENT IV LP","source":"filing","n_filings":9,"first_seen":"2004-06-04","last_seen":"2006-10-20"}],"transactions":[{"id":4179863,"accession":"0001012975-06-000417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-06-000417","line_url":"/filing/0001012975-06-000417#line-2","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"WALTON ALAN G; BARNES JEFFREY T; MRNA FUND II LP; CARTHY MARK; OXFORD BIOSCIENCE PARTNERS IV LP; LYTTON MICHAEL; OBP MANAGEMENT IV LP; FLEMING JONATHAN","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":825056.0,"shares_display":"825,056","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":990067.2,"total_display":"990,067.20","shares_owned_after":10436017.0,"shares_owned_after_display":"10,436,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-18","filed_date":"2006-10-20","scope":"insider"},{"id":4179858,"accession":"0001012975-06-000417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-06-000417","line_url":"/filing/0001012975-06-000417#line-1","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"WALTON ALAN G; BARNES JEFFREY T; MRNA FUND II LP; CARTHY MARK; OXFORD BIOSCIENCE PARTNERS IV LP; LYTTON MICHAEL; OBP MANAGEMENT IV LP; FLEMING JONATHAN","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8278.0,"shares_display":"8,278","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":9933.6,"total_display":"9,933.60","shares_owned_after":104707.0,"shares_owned_after_display":"104,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-18","filed_date":"2006-10-20","scope":"insider"},{"id":3688240,"accession":"0001012975-06-000412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-06-000412","line_url":"/filing/0001012975-06-000412#line-2","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Trubion Pharmaceuticals, Inc","issuer_ticker":"TRBN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; WALTON ALAN G; OBP MANAGEMENT IV LP; CARTHY MARK; FLEMING JONATHAN; LYTTON MICHAEL; BARNES JEFFREY T; MRNA FUND II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41201.0,"shares_display":"41,201","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":535613.0,"total_display":"535,613.00","shares_owned_after":41201.0,"shares_owned_after_display":"41,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-17","filed_date":"2006-10-19","scope":"insider"},{"id":3688237,"accession":"0001012975-06-000412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-06-000412","line_url":"/filing/0001012975-06-000412#line-1","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Trubion Pharmaceuticals, Inc","issuer_ticker":"TRBN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; WALTON ALAN G; OBP MANAGEMENT IV LP; CARTHY MARK; FLEMING JONATHAN; LYTTON MICHAEL; BARNES JEFFREY T; MRNA FUND II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":413.0,"shares_display":"413","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5369.0,"total_display":"5,369.00","shares_owned_after":413.0,"shares_owned_after_display":"413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-17","filed_date":"2006-10-19","scope":"insider"},{"id":1624147,"accession":"0001012975-05-000312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-05-000312","line_url":"/filing/0001012975-05-000312#line-2","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; OBP MANAGEMENT IV LP; CARTHY MARK; MRNA FUND II LP; FLEMING JONATHAN; LYTTON MICHAEL; BARNES JEFFREY T; WALTON ALAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2475166.0,"shares_display":"2,475,166","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":2970199.2,"total_display":"2,970,199.20","shares_owned_after":9610961.0,"shares_owned_after_display":"9,610,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-09-26","filed_date":"2005-09-28","scope":"insider"},{"id":1624146,"accession":"0001012975-05-000312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-05-000312","line_url":"/filing/0001012975-05-000312#line-1","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; OBP MANAGEMENT IV LP; CARTHY MARK; MRNA FUND II LP; FLEMING JONATHAN; LYTTON MICHAEL; BARNES JEFFREY T; WALTON ALAN G","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24834.0,"shares_display":"24,834","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":29800.8,"total_display":"29,800.80","shares_owned_after":96429.0,"shares_owned_after_display":"96,429","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-26","filed_date":"2005-09-28","scope":"insider"},{"id":1337819,"accession":"0001140484-05-000017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140484-05-000017","line_url":"/filing/0001140484-05-000017#line-4","is_derivative":false,"issuer_cik":"0000913275","issuer_name":"Solexa, Inc.","issuer_ticker":"SLXA","issuer_name_source":null,"issuer_url":"/issuer/0000913275","owner_cik":null,"owner_name":"MRNA FUND II LP; OXFORD BIOSCIENCE PARTNERS IV LP; OBP MANAGEMENT IV LP; LYTTON MICHAEL; FLEMING JONATHAN; BARNES JEFFREY T; CARTHY MARK; WALTON ALAN G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":544536.0,"shares_display":"544,536","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2178144.0,"total_display":"2,178,144.00","shares_owned_after":3013522.0,"shares_owned_after_display":"3,013,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-12","filed_date":"2005-07-14","scope":"insider"},{"id":1337818,"accession":"0001140484-05-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140484-05-000017","line_url":"/filing/0001140484-05-000017#line-3","is_derivative":false,"issuer_cik":"0000913275","issuer_name":"Solexa, Inc.","issuer_ticker":"SLXA","issuer_name_source":null,"issuer_url":"/issuer/0000913275","owner_cik":null,"owner_name":"MRNA FUND II LP; OXFORD BIOSCIENCE PARTNERS IV LP; OBP MANAGEMENT IV LP; LYTTON MICHAEL; FLEMING JONATHAN; BARNES JEFFREY T; CARTHY MARK; WALTON ALAN G","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5464.0,"shares_display":"5,464","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":21856.0,"total_display":"21,856.00","shares_owned_after":30235.0,"shares_owned_after_display":"30,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-12","filed_date":"2005-07-14","scope":"insider"},{"id":1297194,"accession":"0001140484-05-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140484-05-000010","line_url":"/filing/0001140484-05-000010#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; WALTON ALAN G; OBP MANAGEMENT IV LP; CARTHY MARK; FLEMING JONATHAN; LYTTON MICHAEL; BARNES JEFFREY T","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":586402.0,"shares_display":"586,402","price_per_share":6.8213,"price_display":"6.82","price_state":"stated","total_value":4000023.9626,"total_display":"4,000,023.96","shares_owned_after":3160238.0,"shares_owned_after_display":"3,160,238","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-04-20","filed_date":"2005-04-21","scope":"insider"},{"id":539754,"accession":"0001286962-04-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001286962-04-000009","line_url":"/filing/0001286962-04-000009#line-2","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"MRNA FUND II LP; WALTON ALAN G; BARNES JEFFREY T; FLEMING JONATHAN; LYTTON MICHAEL; OBP MANAGEMENT IV LP; CARTHY MARK; OXFORD BIOSCIENCE PARTNERS IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315337.0,"shares_display":"315,337","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":946011.0,"total_display":"946,011.00","shares_owned_after":7135795.0,"shares_owned_after_display":"7,135,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-04","filed_date":"2004-11-08","scope":"insider"},{"id":539753,"accession":"0001286962-04-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001286962-04-000009","line_url":"/filing/0001286962-04-000009#line-1","is_derivative":false,"issuer_cik":"0001140484","issuer_name":"Cyberkinetics Neurotechnology Systems, Inc.","issuer_ticker":"CYKN","issuer_name_source":null,"issuer_url":"/issuer/0001140484","owner_cik":null,"owner_name":"MRNA FUND II LP; WALTON ALAN G; BARNES JEFFREY T; FLEMING JONATHAN; LYTTON MICHAEL; OBP MANAGEMENT IV LP; CARTHY MARK; OXFORD BIOSCIENCE PARTNERS IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3164.0,"shares_display":"3,164","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":9492.0,"total_display":"9,492.00","shares_owned_after":71595.0,"shares_owned_after_display":"71,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-04","filed_date":"2004-11-08","scope":"insider"},{"id":336430,"accession":"0001179044-04-000119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179044-04-000119","line_url":"/filing/0001179044-04-000119#line-4","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; MRNA FUND II LP; CARTHY MARK; LYTTON MICHAEL; FLEMING JONATHAN; OBP MANAGEMENT IV LP; BARNES JEFFREY T","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":282169.0,"shares_display":"282,169","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1975183.0,"total_display":"1,975,183.00","shares_owned_after":2573836.0,"shares_owned_after_display":"2,573,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-04","scope":"insider"},{"id":336429,"accession":"0001179044-04-000119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179044-04-000119","line_url":"/filing/0001179044-04-000119#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":null,"owner_name":"OXFORD BIOSCIENCE PARTNERS IV LP; MRNA FUND II LP; CARTHY MARK; LYTTON MICHAEL; FLEMING JONATHAN; OBP MANAGEMENT IV LP; BARNES JEFFREY T","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2831.0,"shares_display":"2,831","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":19817.0,"total_display":"19,817.00","shares_owned_after":25979.0,"shares_owned_after_display":"25,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-02","filed_date":"2004-06-04","scope":"insider"},{"id":9244222,"accession":"0001181431-04-034055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-04-034055","line_url":"/filing/0001181431-04-034055#line-3","is_derivative":false,"issuer_cik":"0001286541","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0001286541","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22022417.0,"shares_display":"22,022,417","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":8808966.8,"total_display":"8,808,966.80","shares_owned_after":43754769.0,"shares_owned_after_display":"43,754,769","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-19","filed_date":"2004-07-02","scope":"insider"},{"id":9244220,"accession":"0001181431-04-034055","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-04-034055","line_url":"/filing/0001181431-04-034055#line-5","is_derivative":false,"issuer_cik":"0001286541","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0001286541","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Secured Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8800966.96,"shares_display":"8,800,966.96","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":3520386.784,"total_display":"3,520,386.78","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-19","filed_date":"2004-07-02","scope":"insider"},{"id":261866,"accession":"0001181431-04-031293","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-04-031293","line_url":"/filing/0001181431-04-031293#line-5","is_derivative":false,"issuer_cik":"0000761237","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0000761237","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Secured Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8770415.43,"shares_display":"8,770,415.43","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":6577811.5725,"total_display":"6,577,811.57","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-19","filed_date":"2004-06-17","scope":"insider"},{"id":261865,"accession":"0001181431-04-031293","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-04-031293","line_url":"/filing/0001181431-04-031293#line-4","is_derivative":false,"issuer_cik":"0000761237","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0000761237","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11693887.0,"shares_display":"11,693,887","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":8770415.25,"total_display":"8,770,415.25","shares_owned_after":26309167.0,"shares_owned_after_display":"26,309,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-19","filed_date":"2004-06-17","scope":"insider"},{"id":9244224,"accession":"0001181431-04-034055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-034055","line_url":"/filing/0001181431-04-034055#line-1","is_derivative":false,"issuer_cik":"0001286541","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0001286541","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500000.0,"shares_display":"5,500,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":2200000.0,"total_display":"2,200,000.00","shares_owned_after":11981482.0,"shares_owned_after_display":"11,981,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-07-02","scope":"insider"},{"id":9244223,"accession":"0001181431-04-034055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-04-034055","line_url":"/filing/0001181431-04-034055#line-2","is_derivative":false,"issuer_cik":"0001286541","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0001286541","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9750870.0,"shares_display":"9,750,870","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":3900348.0,"total_display":"3,900,348.00","shares_owned_after":21732352.0,"shares_owned_after_display":"21,732,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-07-02","scope":"insider"},{"id":9244221,"accession":"0001181431-04-034055","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-04-034055","line_url":"/filing/0001181431-04-034055#line-4","is_derivative":false,"issuer_cik":"0001286541","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0001286541","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Revolving Convertible Senior Secured Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900348.0,"shares_display":"3,900,348","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":1560139.2,"total_display":"1,560,139.20","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-07-02","scope":"insider"},{"id":261864,"accession":"0001181431-04-031293","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-04-031293","line_url":"/filing/0001181431-04-031293#line-3","is_derivative":false,"issuer_cik":"0000761237","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0000761237","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Revolving Convertible Senior Secured Promissory Notes","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900348.0,"shares_display":"3,900,348","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":2925261.0,"total_display":"2,925,261.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-06-17","scope":"insider"},{"id":261863,"accession":"0001181431-04-031293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-04-031293","line_url":"/filing/0001181431-04-031293#line-2","is_derivative":false,"issuer_cik":"0000761237","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0000761237","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5200464.0,"shares_display":"5,200,464","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":3900348.0,"total_display":"3,900,348.00","shares_owned_after":14615280.0,"shares_owned_after_display":"14,615,280","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-06-17","scope":"insider"},{"id":261862,"accession":"0001181431-04-031293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-04-031293","line_url":"/filing/0001181431-04-031293#line-1","is_derivative":false,"issuer_cik":"0000761237","issuer_name":"IMCOR PHARMACEUTICAL CO","issuer_ticker":"ICPHC","issuer_name_source":null,"issuer_url":"/issuer/0000761237","owner_cik":null,"owner_name":"FLEMING JONATHAN; OBP MANAGEMENT IV LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2933334.0,"shares_display":"2,933,334","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":2200000.5,"total_display":"2,200,000.50","shares_owned_after":9414816.0,"shares_owned_after_display":"9,414,816","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-14","filed_date":"2004-06-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001180253","name":"Cyberkinetics Neurotechnology Systems, Inc.","url":"/issuer/0001180253","role":"Ten percent owner","n_filings":3,"first_seen":"2004-11-08","last_seen":"2006-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001298521","name":"Trubion Pharmaceuticals, Inc","url":"/issuer/0001298521","role":"Ten percent owner","n_filings":1,"first_seen":"2006-10-19","last_seen":"2006-10-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000913275","name":"Solexa, Inc.","url":"/issuer/0000913275","role":"Ten percent owner","n_filings":1,"first_seen":"2005-07-14","last_seen":"2005-07-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Ten percent owner","n_filings":2,"first_seen":"2004-06-04","last_seen":"2005-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000761237","name":"IMCOR PHARMACEUTICAL CO","url":"/issuer/0000761237","role":"Ten percent owner","n_filings":2,"first_seen":"2004-06-17","last_seen":"2004-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001286541","retrieved_at":"2026-08-21T18:30:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}